Is Hypofractionation a Good Idea in Radiotherapy for Locally Advanced NSCLC?

J Thorac Oncol. 2022 Apr;17(4):487-488. doi: 10.1016/j.jtho.2022.01.019.

Authors

Paul Martin Putora¹, Dirk K De Ruysscher²

Affiliations

¹ Department of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland; Department of Radiation Oncology, University of Bern, Bern, Switzerland. Electronic address: paulmartin.putora@kssg.ch.
² Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

PMID: 35307104
DOI: 10.1016/j.jtho.2022.01.019

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / radiotherapy
Dose Fractionation, Radiation
Humans
Lung Neoplasms* / radiotherapy
Radiation Dose Hypofractionation